bosentan anhydrous has been researched along with adrenomedullin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, JJ; Lewis, LK; Nicholls, MG; Yandle, TG; Youssef, AH | 1 |
| Gaine, SP; O'Callaghan, D; O'Callaghan, DS | 1 |
1 review(s) available for bosentan anhydrous and adrenomedullin
| Article | Year |
|---|---|
Combination therapy and new types of agents for pulmonary arterial hypertension.
Topics: Adrenomedullin; Angiopoietin-1; Antihypertensive Agents; Benzamides; Bosentan; Drug Therapy, Combination; Eicosanoids; Epoprostenol; Genetic Therapy; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Intracellular Signaling Peptides and Proteins; Piperazines; Platelet Aggregation Inhibitors; Prostaglandins; Protein Serine-Threonine Kinases; Purines; Pyrimidines; rho-Associated Kinases; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sildenafil Citrate; Sulfonamides; Sulfones; Vasoactive Intestinal Peptide; Vasodilator Agents | 2007 |
1 other study(ies) available for bosentan anhydrous and adrenomedullin
| Article | Year |
|---|---|
Effects of endothelin-1 on release of adrenomedullin and C-type natriuretic peptide from individual human vascular endothelial cells.
Topics: Adrenomedullin; Aorta; Bosentan; Cells, Cultured; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Humans; Immune Sera; Immunoblotting; Natriuretic Peptide, C-Type; Oligopeptides; Peptides; Piperidines; Sulfonamides | 2002 |